Create a pitch slide about tyrosine kinase inhibitor study where I want to evaluate its assosciation with proteinuria , primary goal to evaluate incidence based on ICD10 code and compare group that was treated with reducing dose vs. holding dose vs. adding ARB or SGLT2I and what perecenrage stop medication permnantley and its effect on cancer outcome
Create a pitch slide about tyrosine kinase inhibitor study where I want to evaluate its assosciation with proteinuria , primary goal to evaluate incidence based on ICD10 code and compare group that was treated with reducing dose vs. holding dose vs. adding ARB or SGLT2I and what perecenrage stop medication permnantley and its effect on cancer outcome
Created using ChatSlide
This study aims to investigate the association between tyrosine kinase inhibitors (TKIs) and proteinuria, utilizing ICD-10 codes to measure incidence and define clinical endpoints. It will compare management strategies, including dose reduction and the use of ARB/SGLT2 inhibitors, while adjusting for cancer type and baseline risk. Additionally, the research will quantify permanent medication discontinuation, assess treatment changes, and derive insights into renal-oncology outcomes.